Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications.
We are the pioneer developer of the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, a unique proprietary endoscopic device for the treatment of gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world.
The MUSE system, our flagship medical device, addresses the unmet need in between drug therapy and invasive surgery for the long-term treatment of GERD (gastroesophageal reflux disease), commonly referred to as acid reflux.
We have also developed minimally invasive endosurgical tools and highly innovative imaging solutions - www.scoutcam.com
Our innovative visualization solutions are suitable for a variety of medical, industrial, aerospace, defense and research applications and can be customized to meet a range of needs across applications. In fact, we design and manufacture endoscopy and micro camera systems for some of the biggest medical and industrial companies in the world.
Medigus stock is traded in the U.S. on the Nasdaq and in Israel on the Tel Aviv Stock Exchange (TASE) under the ticker “MDGS”.